REALIXIA
Rising Demand for Biologics Boosts Cell Line Development Across North America
The Cell Line Development Market in North America is witnessing steady growth as pharmaceutical and biotechnology companies increasingly utilize mammalian and other cell-based systems for the development and manufacturing of biologics. Market Overview The cell line development market was valued at US$ 6.86 billion in 2023 and is expected to reach US$ 18.62 billion by 2031. The market is...
881 Просмотры